Asymptomatic SARS-CoV-2 infection in children in children – if and how should they be monitored in the following months of the pandemic?
Sylwia Chodubska1 | Anna Opyrchał1 | Agnieszka Wypych1 | Anna Komaszyńska1 | Paweł Grzesiowski2, 3 | Agnieszka Sulikowska1
Assessment of the in vitro sensitivity of bacterial pathogens to ceftaroline and comparator antibiotics Frequently Used in Poland in skin and soft tissue infections in paediatric and adult populations: data from ATLAS surveillance program 2013–2018
Małgorzata B. Prażyńska1 | Łukasz Pojnar2 | Patrycja Zalas-Więcek1 | Eugenia Gospodarek-Komkowska1 | Jolanta Kędzierska2 | Anna Kujawska2 | Barbara Możejko-Pastewka3 | Monika Bogiel3
Prevention of infections in premature babies and newborns – which antiseptic should you choose?
Monika Oleksy-Wawrzyniak1 | Malwina Brożyna1 | Elżbieta Piątkowska1 | Kinga Niewińska2 | Marzenna Bartoszewicz1
Carbapenems – microbiology and pharmacology
Jarosław Woroń1, 2 | Beata Kowalska-Krochmal3
Intravenous administration of amoxicillin/clavulanic acid at a dose of 2000 mg + 200 mg
Kinga Bondarczuk
Nitroxoline, a valuable therapeutic option in urinary tract infections
Jarosław Woroń1, 2
Microbiological tests in pregnant women – standards of conduct
Agnieszka Sikora1 | Anna Sikora-Futyma2 | Marzena Laskowska3
Piotr Kacprzyk
Asymptomatic SARS-CoV-2 infection in children in children – if and how should they be monitored in the following months of the pandemic?
Sylwia Chodubska1 | Anna Opyrchał1 | Agnieszka Wypych1 | Anna Komaszyńska1 | Paweł Grzesiowski2, 3 | Agnieszka Sulikowska1